272 related articles for article (PubMed ID: 23379410)
21. A typical mood stabilizers: a "typical role for atypical antipsychotics.
Malhi GS; Berk M; Bourin M; Ivanovski B; Dodd S; Lagopoulos J; Mitchell PB
Acta Psychiatr Scand Suppl; 2005; (426):29-38. PubMed ID: 16104066
[TBL] [Abstract][Full Text] [Related]
22. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
Erbe S; Gutwinski S; Bschor T
Psychiatr Prax; 2012 Mar; 39(2):57-63. PubMed ID: 22189902
[TBL] [Abstract][Full Text] [Related]
23. Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia.
Guirguis-Blake J
Am Fam Physician; 2010 Jun; 81(11):1335-6. PubMed ID: 20521753
[No Abstract] [Full Text] [Related]
24. Atypical antipsychotics in the treatment of children and adolescents: clinical applications.
Findling RL; McNamara NK
J Clin Psychiatry; 2004; 65 Suppl 6():30-44. PubMed ID: 15104524
[TBL] [Abstract][Full Text] [Related]
25. FDA warns antipsychotic drugs may be risky for elderly.
Kuehn BM
JAMA; 2005 May; 293(20):2462. PubMed ID: 15914734
[No Abstract] [Full Text] [Related]
26. Atypical antipsychotic medications in the management of disruptive behaviors in children: safety guidelines and recommendations.
McKinney C; Renk K
Clin Psychol Rev; 2011 Apr; 31(3):465-71. PubMed ID: 21130552
[TBL] [Abstract][Full Text] [Related]
27. Optimizing atypical antipsychotic treatment strategies in the elderly.
Katz IR
J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S272-7. PubMed ID: 15541168
[No Abstract] [Full Text] [Related]
28. Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.
Moons T; Claes S; Martens GJ; Peuskens J; Van Loo KM; Van Schijndel JE; De Hert M; van Winkel R
Schizophr Res; 2011 Feb; 125(2-3):187-93. PubMed ID: 21050724
[TBL] [Abstract][Full Text] [Related]
29. A model of anticholinergic activity of atypical antipsychotic medications.
Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G
Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430
[TBL] [Abstract][Full Text] [Related]
30. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
Correll CU; Manu P; Olshanskiy V; Napolitano B; Kane JM; Malhotra AK
JAMA; 2009 Oct; 302(16):1765-73. PubMed ID: 19861668
[TBL] [Abstract][Full Text] [Related]
31. Akathisia and second-generation antipsychotic drugs.
Kumar R; Sachdev PS
Curr Opin Psychiatry; 2009 May; 22(3):293-99. PubMed ID: 19378382
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of atypical antipsychotics in elderly patients with dementia.
Tariot PN; Profenno LA; Ismail MS
J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966
[TBL] [Abstract][Full Text] [Related]
33. Adjunctive antipsychotics for major depression.
Med Lett Drugs Ther; 2011 Sep; 53(1373):74-5. PubMed ID: 21921872
[No Abstract] [Full Text] [Related]
34. Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
Lorenz RA; Jackson CW; Saitz M
Pharmacotherapy; 2010 Sep; 30(9):942-51. PubMed ID: 20795849
[TBL] [Abstract][Full Text] [Related]
35. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
[TBL] [Abstract][Full Text] [Related]
36. The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913).
Hanssens L; L'Italien G; Loze JY; Marcus RN; Pans M; Kerselaers W
BMC Psychiatry; 2008 Dec; 8():95. PubMed ID: 19102734
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews.
Melnik T; Soares BG; Puga ME; Atallah AN
Sao Paulo Med J; 2010 May; 128(3):141-66. PubMed ID: 20963366
[TBL] [Abstract][Full Text] [Related]
38. Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
Peritogiannis V; Tsouli S
J Psychopharmacol; 2010 Jul; 24(7):1121-5. PubMed ID: 19395427
[TBL] [Abstract][Full Text] [Related]
39. Role of atypical antipsychotics in the treatment of generalized anxiety disorder.
Hershenberg R; Gros DF; Brawman-Mintzer O
CNS Drugs; 2014 Jun; 28(6):519-33. PubMed ID: 24794100
[TBL] [Abstract][Full Text] [Related]
40. [Expectations and developments in atypical antipsychotics].
Praxis (Bern 1994); 2004 Aug; 93(35):1392. PubMed ID: 15468579
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
